SCHEMBL15613565

SCHEMBL15613565

Cc1ccc(COc2cc(F)cc(Oc3ccc(-c4nn(CC5(C)COC5)c5ncnc(N)c45)cc3)c2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.54
▸ BTK Q06187 12/20 0.44
▸ PIK3CA P42336 2/20 0.43
▸ PIK3CG P48736 2/20 0.43
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ SRC P12931 4/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ FYN P06241 3/20 0.39
▸ MAP2K5 Q13163 2/20 0.39
▸ BMX P51813 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ NUDT14 O95848 1/20 0.39
▸ NUDT5 Q9UKK9 1/20 0.39
▸ LCK P06239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15613644 0.93 KCNH2 (0.55) KCNH2BTKPIK3CAPIK3CGPIK3CD
SCHEMBL15613567 0.87 KCNH2 (0.56) KCNH2BTKPIK3CAPIK3CGSRC
SCHEMBL16886202 0.87 KCNH2 (0.55) KCNH2BTKPIK3CAPIK3CGSRC
SCHEMBL15613563 0.86 KCNH2 (0.53) KCNH2BTKPIK3CAPIK3CGPIK3CD
SCHEMBL16886191 0.86 KCNH2 (0.54) KCNH2BTKPIK3CAPIK3CGPIK3CD
SCHEMBL15613545 0.85 SRC (0.48) BTKPIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL15613537 0.84 CYP1A2 (0.47) BTKPIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL15613690 0.84 BTK (0.46) BTKPIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL15613585 0.82 BTK (0.51) BTKPIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL15613627 0.82 SRC (0.59) PIK3CAPIK3CGPIK3CDPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796716-B2 Selective inhibitors of Tec and Src protein kinase families PHARMASCIENCE, INC. (CA) 2017-10-24 — — US disclosed
US-9796716-B2 Selective inhibitors of Tec and Src protein kinase families PHARMASCIENCE, INC. (CA) 2017-10-24 — — US disclosed
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 — — US disclosed
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 — — US disclosed
WO-2013177668-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2013-12-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK KCNH2 4209/4885BTK 10/4885PIK3CA 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback